The Americas In 2007, Poser and Brinar 1 noted that published prevalence rates of multiple
sclerosis (MS) could be misleading with the reliance on clinical information and brain MRI …

Acute optic neuritis is the most common optic neuropathy affecting young adults. Exciting
developments have occurred over the past decade in understanding of optic neuritis …

Background Pharmacological prevention against relapses in patients with neuromyelitis
optica spectrum disorder (NMOSD) is developing rapidly. We aimed to investigate the safety …

Background Azathioprine is used as a first-line treatment to prevent relapses of
neuromyelitis optica spectrum disorder (NMOSD). Tocilizumab has been reported to reduce …

Objective Neuromyelitis optica (NMO) attacks often are severe, are difficult to treat, and
leave residual deficits. Here, we analyzed the frequency, sequence, and efficacy of …

Neuromyelitis optica (NMO, Devic's syndrome), long considered a clinical variant of multiple
sclerosis, is now regarded as a distinct disease entity. Major progress has been made in the …

Objective To report the clinical, radiological, and immunological association of
demyelinating disorders with anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis …

Objective: We aimed to report the frequency and implications of antibodies to myelin
oligodendrocyte glycoprotein (MOG-ab) in adults with demyelinating syndromes suspicious …

Background Myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) are related to
several acquired demyelinating syndromes in adults, but the therapeutic approach is …

Introduction While monophasic and relapsing forms of myelin oligodendrocyte glycoprotein
antibody associated disorders (MOGAD) are increasingly diagnosed world-wide, consensus …